CureMatch Articles & News
Innovation in these companies varies from better user experiences to democratizing access. From health care to the short-term rental market, these 15 technology-related companies are leading their industry in creativity and innovation. Navid Alipour, co-founder and CEO of CureMetrix and CureMatch, brings AI-based technology to health care, focused on improving clinical and financial outcomes. See […]
In this interview series called, “5 Things Everyone Needs To Know About Cancer” we are talking to experts about cancer such as oncologists, researchers, and medical directors to address these questions. As a part of this interview series, I had the pleasure of interviewing oncologist, Dr. Razelle Kurzrock. Dr. Razelle Kurzrock is a board-certified medical […]
Malignancies are molecularly complex and become more resistant with each line of therapy. We hypothesized that offering matched, individualized combination therapies to patients with treatment-naïve, advanced cancers would be feasible and efficacious. Patients with newly diagnosed unresectable/metastatic, poorprognosis cancers were enrolled in a cross-institutional prospective study. A total of 145 patients were included in the […]
Today, Ally Perlina, CureMatch Chief Science Officer was recognized as a Woman of Influence for Life Science by the San Diego Business Journal. Ally Perlina is a visionary innovator who translates complex data into scalable products. As Chief Science Officer for CureMatch, Inc., a San Diego company delivering groundbreaking artificial intelligence (AI) technology for clinical […]
Today, most oncologists know that a one-size-fits-all approach may not result in optimal cancer treatment, which can encompass chemotherapy, radiation therapy, surgery, infusions and a large number of other drugs. As recent research reveals, each patient’s cancer and the actual molecular profile of each patient’s tumor is unique in nature – and so should their […]